Dr. Shashita Inamdar MD, PhD, is a neuropsychiatrist and Co-Founder of SokyaHealth. She will be discussing the first and only FDA-approved, ketamine-based therapy for treatment resistant depression. Intranasal Spravato (esketamine nasal spray) is also indicated for MDD with acute suicidal ideation or behavior.
Please join us for dinner and lively conversation about depression treatment, including clinical experience discussion, at Jens’ on March 28!
Discussion
By posting you agree to the Terms and Privacy Policy.